Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

FLUDEOXYGLUCOSE F18

FLUDEOXYGLUCOSE F-18

Standard Dose
20-240mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview FLUDEOXYGLUCOSE F18 is listed in Drugs@FDA under application 203612 (ANDA).

Marketing status: Prescription Active ingredient FLUDEOXYGLUCOSE F-18 Form and strength INJECTABLE;INTRAVENOUS - 20-240mCi/ML Sponsor MCPRF Submission history Latest submission status date: 2013-08-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLUDEOXYGLUCOSE F18 is listed in Drugs@FDA under application 203612 (ANDA). Marketing status: Prescription Active ingredient FLUDEOXYGLUCOSE F-18 Form and strength INJECTABLE;INTRAVENOUS - 20-240mCi/ML Sponsor MCPRF Submission history Latest submission status date: 2013-08-05 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.
FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F-18) | Drug Monograph | MedicHelpline